| Literature DB >> 30859330 |
Josefine E Naili1, Margareta Hedström2,3, Eva W Broström4.
Abstract
BACKGROUND: The aim of this prospective study is to evaluate the degree of improvement in, and interrelationships between, performance-based function, gait, and patient-reported function 1 year after total hip arthroplasty (THA) in patients with primary hip osteoarthritis (OA).Entities:
Keywords: Arthroplasty; Function; Gait; Hip; Mobility; Osteoarthritis; Performance
Mesh:
Year: 2019 PMID: 30859330 PMCID: PMC6411808 DOI: 10.1186/s10195-019-0521-7
Source DB: PubMed Journal: J Orthop Traumatol ISSN: 1590-9921
Baseline characteristics of patients with hip osteoarthritis and healthy controls included in the study
| Hip osteoarthritis ( | Healthy controls ( | Difference between groups | |
|---|---|---|---|
| Mean (SD) age (years) | 66.9 (9.0) | 65.7 (9.5) | 0.60 |
| 40–49 years, | 2 (6) | 1 (4) | |
| 50–59 years, | 7 (21) | 5 (29) | |
| 60–69 years, | 9 (26) | 9 (36) | |
| 70–79 years, | 15 (44) | 9 (36) | |
| 89–89 years, | 1 (3) | 1 (4) | |
| Female, | 24 (71) | 16 (64) | |
| Mean (SD) body mass index (kg/m2) | 26.6 (3.8) | 24.9 (2.9) | 0.07 |
| Mean (SD) body weight (kg) | 76.3 (15) | 72.8 (12.2) | 0.35 |
| Mean (SD) height (cm) | 169 (10) | 171 (8) | 0.40 |
| Mean (SD) symptom duration (years) | 4.3 (3.4) | NA | |
| Kellgren–Lawrence score (1–4) | |||
| 1–2, | – | NA | |
| 3, | 10 (29) | NA | |
| 4, | 24 (71) | NA | |
| Use of analgesics | |||
| Daily use, | 19 (56) | NA | |
| If necessary (when needed), | 13 (38) | NA | |
| Never (rarely), | 2 (6) | NA | |
Fig. 1Flowchart of included study participants with hip osteoarthritis, test procedures, excluded individuals, and study participants completing the 1-year follow-up
Functional outcomes at baseline prior to total hip arthroplasty and at 1-year follow-up in patients with hip osteoarthritis and healthy controls
| Hip osteoarthritis ( | Healthy controls ( | ||||
|---|---|---|---|---|---|
| Pre-THA mean (SD) | Mean change (SD) | Effect size (95 % CI) | Post-THA mean (SD) | Control group mean (SD) | |
| Performance-based function | |||||
| Five Times Sit to Stand Test | 15.7 (6.8) | −4.1 (6.7)* | 0.9 (0.3–1.4) | 11.6 (2.9) | 9.9 (2.9)* |
| Timed Up and Go Test | 12.5 (2.2) | −1.6 (2.1)
| 1.1 (0.5–1.6) | 10.9 (1.6) | 8.8 (1.4)
|
| Single Limb Mini Squat test | 19.6 (7.7) | 4.7 (7.9)* | 0.8 (0.3–1.4) | 24.4 (9.1) | 29.3 (10.9) |
| Overall gait pattern | |||||
| GDI, operated limb | 85.3 (9.0) | 6.9 (13.3)* | 0.7 (0.3–1.2) | 92.2 (11.2) | 96.6 (9) |
| GDI, nonoperated limb | 89.6 (9.7) | 4.5 (12.1)* | 0.5 (0.0–1.0) | 94.1 (9.3) | 96.6 (9) |
| GDI-kinetic, operated limb | 92.5 (6.3) | 2.8 (9.5) | 0.4 (0.0–0.9) | 95.4 (8.6) | 100 (8.6)* |
| GDI-kinetic, nonoperated limb | 90.4 (8.3) | 4.7 (10.1)* | 0.7 (0.2–1.2) | 95.1 (10.7) | 100 (8.6) |
| Time and distance parameters | |||||
| Walking speed (m/s) | 1.1 (0.3) | 0.1 (0.3)* | 0.8 (0.3–1.3) | 1.2 (0.2) | 1.3 (0.2)* |
| Normalized walking speed | 0.36 (0.05) | 0.04 (0.06)
| 0.9 (0.4–1.5) | 0.40 (0.06) | 0.44 (0.06)* |
| Stride length (m) | 1.14 (0.13) | 0.08 (0.09)
| 1.2 (0.6–1.7) | 1.21 (0.12) | 1.34 (0.11)
|
| Patient-reported function | |||||
| HOOS symptoms | 40 (14) | 42 (17)
| 3.4 (2.5–4.4) | 82 (14) | 95 (6)
|
| HOOS pain | 44 (12) | 42 (17)
| 3.6 (2.6–4.5) | 86 (13) | 97 (5)
|
| HOOS ADL | 50 (14) | 37 (18)
| 2.9 (2.0–3.7) | 87 (13) | 96 (7)* |
| HOOS sport and recreation | 26 (17) | 42 (29)
| 2.1 (1.4–2.7) | 69 (24) | 98 (9)
|
| HOOS quality of life | 28 (15) | 44 (19)
| 3.2 (2.3–4.1) | 72 (17) | 95 (8)
|
ADL activities of daily living, GDI Gait Deviation Index, HOOS Hip disability and Osteoarthritis Outcome Score
* p < 0.05, p < 0.001. Paired-sample t tests were used to compare pre- and postoperative results within the hip osteoarthritis group and are reported in the column for mean change. Independent-sample t tests were used to compare postoperative results of the hip osteoarthritis group with the control group and are reported in the column for control group mean
Fig. 2Overall gait pattern, evaluated using the Gait Deviation Index for kinematics (GDI) and kinetics (GDI-kinetic), at baseline and at 1 year after total hip arthroplasty in (n = 34) patients with hip osteoarthritis. Patients grouped by postoperative change in performance-based function
Fig. 3Patient-reported function and pain, evaluated using the Hip disability and Osteoarthritis Outcome Score, at baseline and 1-year follow-up after total hip arthroplasty in (n = 34) patients with hip osteoarthritis. Patients grouped by postoperative change in performance-based function. ADL, activities of daily living; QoL, hip-related quality of life